Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.

Attarbaschi A, Mann G, Zimmermann M, Bader P, Barisone E, Basso G, Biondi A, Cario G, Cazzaniga G, Colombini A, Flotho C, Kuhlen M, Lang P, Lauten M, Linderkamp C, Locatelli F, Lo Nigro L, Möricke A, Niggli F, Panzer-Grümayer R, Parasole R, Peters C, Caterina Putti M, Rizzari C, Suttorp M, Valsecchi MG, Conter V, Schrappe M; on behalf of the AIEOP-BFM (Associazione Italiana di Ematologia e Oncologia Pediatrica & Berlin-Frankfurt-Münster) Study Group.

Leukemia. 2019 Dec 5. doi: 10.1038/s41375-019-0670-y. [Epub ahead of print] No abstract available.

PMID:
31806872
2.

PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients.

Franca R, Stocco G, Favretto D, Giurici N, Del Rizzo I, Locatelli F, Vinti L, Biondi A, Colombini A, Fagioli F, Barisone E, Pelin M, Martellossi S, Ventura A, Decorti G, Rabusin M.

Pharmacogenomics J. 2019 Dec 3. doi: 10.1038/s41397-019-0130-0. [Epub ahead of print]

PMID:
31792371
3.

Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study.

Testi AM, Attarbaschi A, Valsecchi MG, Möricke A, Cario G, Niggli F, Silvestri D, Bader P, Kuhlen M, Parasole R, Putti MC, Lang P, Flotho C, Mann G, Rizzari C, Barisone E, Locatelli F, Linderkamp C, Lauten M, Suttorp M, Zimmermann M, Basso G, Biondi A, Conter V, Schrappe M; AIEOP-BFM (Associazione Italiana di Ematologia e Oncologia Pediatrica & Berlin-Frankfurt-Münster) Study Group.

Eur J Cancer. 2019 Nov;122:61-71. doi: 10.1016/j.ejca.2019.09.004. Epub 2019 Oct 17.

PMID:
31629941
4.

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study.

Rizzari C, Lanvers-Kaminsky C, Valsecchi MG, Ballerini A, Matteo C, Gerss J, Wuerthwein G, Silvestri D, Colombini A, Conter V, Biondi A, Schrappe M, Moericke A, Zimmermann M, von Stackelberg A, Linderkamp C, Frühwald MC, Legien S, Attarbaschi A, Reismüller B, Kasper D, Smisek P, Stary J, Vinti L, Barisone E, Parasole R, Micalizzi C, Zucchetti M, Boos J.

Haematologica. 2019 Sep;104(9):1812-1821. doi: 10.3324/haematol.2018.206433. Epub 2019 Jan 31.

5.

Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP).

Parasole R, Valsecchi MG, Silvestri D, Locatelli F, Barisone E, Petruzziello F, Putti MC, Micalizzi C, Colombini A, Mura R, Mina T, Testi AM, Notarangelo LD, Santoro N, Casini T, Consarino C, Nigro LL, Ziino O, Giagnuolo G, Rizzari C, Conter V.

Blood Cancer J. 2018 Nov 15;8(12):115. doi: 10.1038/s41408-018-0150-z. No abstract available.

6.

Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).

Schrappe M, Bleckmann K, Zimmermann M, Biondi A, Möricke A, Locatelli F, Cario G, Rizzari C, Attarbaschi A, Valsecchi MG, Bartram CR, Barisone E, Niggli F, Niemeyer C, Testi AM, Mann G, Ziino O, Schäfer B, Panzer-Grümayer R, Beier R, Parasole R, Göhring G, Ludwig WD, Casale F, Schlegel PG, Basso G, Conter V.

J Clin Oncol. 2018 Jan 20;36(3):244-253. doi: 10.1200/JCO.2017.74.4946. Epub 2017 Nov 17.

7.

CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia.

Palmi C, Savino AM, Silvestri D, Bronzini I, Cario G, Paganin M, Buldini B, Galbiati M, Muckenthaler MU, Bugarin C, Della Mina P, Nagel S, Barisone E, Casale F, Locatelli F, Lo Nigro L, Micalizzi C, Parasole R, Pession A, Putti MC, Santoro N, Testi AM, Ziino O, Kulozik AE, Zimmermann M, Schrappe M, Villa A, Gaipa G, Basso G, Biondi A, Valsecchi MG, Stanulla M, Conter V, Te Kronnie G, Cazzaniga G.

Oncotarget. 2016 Sep 13;7(37):59260-59272. doi: 10.18632/oncotarget.10610.

8.

Spiritual support for adolescent cancer patients: a survey of pediatric oncology centers in Italy and Spain.

Proserpio T, Veneroni L, Silva M, Lassaletta A, Lorenzo R, Magni C, Bertolotti M, Barisone E, Mascarin M, Jankovic M, D'Angelo P, Clerici CA, Garrido-Colino C, Gutierrez-Carrasco I, Echebarria A, Biondi A, Massimino M, Casale F, Tamburini A, Ferrari A.

Tumori. 2016 Aug 3;102(4):376-80. doi: 10.5301/tj.5000494. Epub 2016 May 6.

PMID:
27151878
9.

"There's no reason why": a campaign to raise cancer awareness among adolescents.

Magni C, Maggioni F, Ricci A, Barisone E, Jankovic M, Postiglione ES, Cargnel E, Barricelli BR, Valtolina S, Veneroni L, Chiaravalli S, Lapidari P, Capelletti M, Clerici CA, Biondi A, Ferrari A.

Tumori. 2016 Jun 2;2016(3):270-5. doi: 10.5301/tj.5000493. Epub 2016 Mar 26.

PMID:
27032701
10.

Adolescents with Cancer in Italy: Improving Access to National Cooperative Pediatric Oncology Group (AIEOP) Centers.

Ferrari A, Rondelli R, Pession A, Mascarin M, Buzzoni C, Mosso ML, Maule M, Barisone E, Bertolotti M, Clerici CA, Jankovic M, Fagioli F, Biondi A.

Pediatr Blood Cancer. 2016 Jun;63(6):1116-9. doi: 10.1002/pbc.25954. Epub 2016 Feb 23.

PMID:
26914476
11.

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.

Möricke A, Zimmermann M, Valsecchi MG, Stanulla M, Biondi A, Mann G, Locatelli F, Cazzaniga G, Niggli F, Aricò M, Bartram CR, Attarbaschi A, Silvestri D, Beier R, Basso G, Ratei R, Kulozik AE, Lo Nigro L, Kremens B, Greiner J, Parasole R, Harbott J, Caruso R, von Stackelberg A, Barisone E, Rössig C, Conter V, Schrappe M.

Blood. 2016 Apr 28;127(17):2101-12. doi: 10.1182/blood-2015-09-670729. Epub 2016 Feb 17.

PMID:
26888258
12.

Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.

Conter V, Valsecchi MG, Buldini B, Parasole R, Locatelli F, Colombini A, Rizzari C, Putti MC, Barisone E, Lo Nigro L, Santoro N, Ziino O, Pession A, Testi AM, Micalizzi C, Casale F, Pierani P, Cesaro S, Cellini M, Silvestri D, Cazzaniga G, Biondi A, Basso G.

Lancet Haematol. 2016 Feb;3(2):e80-6. doi: 10.1016/S2352-3026(15)00254-9. Epub 2016 Jan 26.

PMID:
26853647
13.

Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia.

Paganin M, Fabbri G, Conter V, Barisone E, Polato K, Cazzaniga G, Giraldi E, Fagioli F, Aricò M, Valsecchi MG, Basso G.

J Clin Oncol. 2014 Nov 1;32(31):3553-8. doi: 10.1200/JCO.2014.56.0698. Epub 2014 Oct 6.

PMID:
25287825
14.

Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study.

Parasole R, Petruzziello F, Messina C, Barisone E, Pession A, Locatelli F, Micalizzi C, Cesaro S, Testi AM, De Matteo A, Varotto S, Berger M, Morello W, Menna G, Poggi V.

Leuk Lymphoma. 2015 Mar;56(3):650-5. doi: 10.3109/10428194.2014.927456. Epub 2014 Aug 4.

PMID:
24882262
15.

Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study.

Conter V, Valsecchi MG, Parasole R, Putti MC, Locatelli F, Barisone E, Lo Nigro L, Santoro N, Aricò M, Ziino O, Pession A, Testi AM, Micalizzi C, Casale F, Zecca M, Casazza G, Tamaro P, La Barba G, Notarangelo LD, Silvestri D, Colombini A, Rizzari C, Biondi A, Masera G, Basso G.

Blood. 2014 Mar 6;123(10):1470-8. doi: 10.1182/blood-2013-10-532598. Epub 2014 Jan 10.

PMID:
24415536
16.

Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia.

Lo Nigro L, Mirabile E, Tumino M, Caserta C, Cazzaniga G, Rizzari C, Silvestri D, Buldini B, Barisone E, Casale F, Luciani M, Locatelli F, Messina C, Micalizzi C, Pession A, Parasole R, Santoro N, Masera G, Basso G, Aricò M, Valsecchi M, Biondi A, Conter V; AIEOP—Scientific Committee of ALL.

Leukemia. 2013 Dec;27(12):2419-21. doi: 10.1038/leu.2013.149. Epub 2013 May 14. No abstract available.

PMID:
23670296
17.

Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience.

Santoro N, Colombini A, Silvestri D, Grassi M, Giordano P, Parasole R, Barisone E, Caruso R, Conter V, Valsecchi MG, Masera G, Rizzari C.

J Pediatr Hematol Oncol. 2013 Jul;35(5):348-55. doi: 10.1097/MPH.0b013e31828dc614.

PMID:
23619106
18.

FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients.

Quarello P, Berger M, Rivetti E, Galletto C, Masetti R, Manicone R, Barisone E, Pession A, Fagioli F.

J Pediatr Hematol Oncol. 2012 Apr;34(3):208-16. doi: 10.1097/MPH.0b013e3182427593.

PMID:
22395219
19.

Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients.

Miano M, Pistorio A, Putti MC, Dufour C, Messina C, Barisone E, Ziino O, Parasole R, Luciani M, Lo Nigro L, De Rossi G, Varotto S, Bertorello N, Petruzziello F, Calvillo M, Micalizzi C.

Leuk Lymphoma. 2012 Sep;53(9):1693-8. doi: 10.3109/10428194.2012.663915. Epub 2012 Mar 13.

PMID:
22303898
20.

Physical activity and late effects in childhood acute lymphoblastic leukemia long-term survivors.

Bertorello N, Manicone R, Galletto C, Barisone E, Fagioli F.

Pediatr Hematol Oncol. 2011 Aug;28(5):354-63. doi: 10.3109/08880018.2010.550987. Epub 2011 Mar 17.

PMID:
21413831
21.

Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.

Pillon M, Aricò M, Basso G, Locatelli F, Citterio M, Micalizzi C, Testi AM, Barisone E, Nardi M, Lombardi A, Rondelli R, Rosolen A; NHL-Committee of the Italian Association of Pediatric Hematology, Oncology.

Pediatr Blood Cancer. 2011 Apr;56(4):544-50. doi: 10.1002/pbc.22787. Epub 2010 Dec 15.

PMID:
21298738
22.

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.

Conter V, Bartram CR, Valsecchi MG, Schrauder A, Panzer-Grümayer R, Möricke A, Aricò M, Zimmermann M, Mann G, De Rossi G, Stanulla M, Locatelli F, Basso G, Niggli F, Barisone E, Henze G, Ludwig WD, Haas OA, Cazzaniga G, Koehler R, Silvestri D, Bradtke J, Parasole R, Beier R, van Dongen JJ, Biondi A, Schrappe M.

Blood. 2010 Apr 22;115(16):3206-14. doi: 10.1182/blood-2009-10-248146. Epub 2010 Feb 12.

23.

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia.

Conter V, Aricò M, Basso G, Biondi A, Barisone E, Messina C, Parasole R, De Rossi G, Locatelli F, Pession A, Santoro N, Micalizzi C, Citterio M, Rizzari C, Silvestri D, Rondelli R, Lo Nigro L, Ziino O, Testi AM, Masera G, Valsecchi MG; Associazione Italiana di Ematologia ed Oncologia Pediatrica.

Leukemia. 2010 Feb;24(2):255-64. doi: 10.1038/leu.2009.250. Epub 2009 Dec 17.

PMID:
20016536
24.

Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol.

Hempel G, Relling MV, de Rossi G, Stary J, De Lorenzo P, Valsecchi MG, Barisone E, Boos J, Pieters R.

Pediatr Blood Cancer. 2010 Mar;54(3):355-60. doi: 10.1002/pbc.22266.

PMID:
19731319
25.

Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph+ acute leukemias.

Marangon E, Citterio M, Sala F, Barisone E, Lippi AA, Rizzari C, Biondi A, D'Incalci M, Zucchetti M.

Cancer Chemother Pharmacol. 2009 Feb;63(3):563-6. doi: 10.1007/s00280-008-0764-0. Epub 2008 Jun 3. No abstract available.

PMID:
18521606
26.

Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.

Aricò M, Valsecchi MG, Rizzari C, Barisone E, Biondi A, Casale F, Locatelli F, Lo Nigro L, Luciani M, Messina C, Micalizzi C, Parasole R, Pession A, Santoro N, Testi AM, Silvestri D, Basso G, Masera G, Conter V.

J Clin Oncol. 2008 Jan 10;26(2):283-9. doi: 10.1200/JCO.2007.12.3927.

PMID:
18182669
27.

Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.

Einaudi S, Bertorello N, Masera N, Farinasso L, Barisone E, Rizzari C, Corrias A, Villa A, Riva F, Saracco P, Pastore G.

Pediatr Blood Cancer. 2008 Mar;50(3):537-41.

PMID:
17828747
28.

Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study.

Farinasso L, Bertorello N, Garbarini L, Gajno TM, Barisone E, Artesani L, Valori A, Giacchino M, Pastore G, Saracco P.

Leukemia. 2007 Mar;21(3):552-6. Epub 2007 Feb 1. No abstract available.

PMID:
17268522
29.

Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia.

Te Kronnie G, Bicciato S, Franceschini L, Accordi B, Dellíorto MC, Rinaldi A, Pession A, Barisone E, Conter V, Locatelli F, Basso G.

Oncol Rep. 2006 Feb;15(2):341-6.

PMID:
16391852
30.

The MIF-173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia.

Ziino O, D'Urbano LE, De Benedetti F, Conter V, Barisone E, De Rossi G, Basso G, Aricò M.

Leukemia. 2005 Dec;19(12):2346-7. No abstract available.

PMID:
16208413
31.

Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study.

Aricò M, Conter V, Valsecchi MG, Rizzari C, Boccalatte MF, Barisone E, Messina C, De Rossi G, Lo Nigro L, Pession A, Locatelli F, Micalizzi C, Basso G.

Haematologica. 2005 Sep;90(9):1186-91.

32.

Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase.

Saracco P, Bertorello N, Farinasso L, Einaudi S, Barisone E, Altare F, Corrias A, Pastore G.

J Pediatr Hematol Oncol. 2005 Mar;27(3):141-4. Erratum in: J Pediatr Hematol Oncol. 2005 Apr;27(4):242. Corrias, Andrea [added].

PMID:
15750445
33.

GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children.

Testi AM, Biondi A, Lo Coco F, Moleti ML, Giona F, Vignetti M, Menna G, Locatelli F, Pession A, Barisone E, De Rossi G, Diverio D, Micalizzi C, Aricò M, Basso G, Foa R, Mandelli F.

Blood. 2005 Jul 15;106(2):447-53. Epub 2005 Jan 27.

PMID:
15677559
34.

Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy.

Fioredda F, Plebani A, Hanau G, Haupt R, Giacchino M, Barisone E, Balbo L, Castagnola E.

Eur J Haematol. 2005 Jan;74(1):20-3.

PMID:
15613102
35.

Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.

Aricò M, Boccalatte MF, Silvestri D, Barisone E, Messina C, Chiesa R, Santoro N, Tamaro P, Lippi A, Gallisai D, Basso G, De Rossi G; Associazione Italiana di Ematologia ed Oncologia Pediatrica.

Haematologica. 2003 Jul;88(7):747-53.

36.

A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group.

Testi AM, Del Giudice I, Arcese W, Moleti ML, Giona F, Basso G, Biondi A, Conter V, Messina C, Rondelli R, Micozzi A, Micalizzi C, Barisone E, Locatelli F, Dini G, Aricò M, Casale F, Comis M, Ladogana S, Lippi A, Mura R, Pinta MF, Santoro N, Valsecchi MG, Masera G, Mandelli F; AIEOP Cooperative Group.

Br J Haematol. 2002 Sep;118(3):741-7.

PMID:
12181040
37.

Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.

Aricò M, Valsecchi MG, Conter V, Rizzari C, Pession A, Messina C, Barisone E, Poggi V, De Rossi G, Locatelli F, Micalizzi MC, Basso G, Masera G.

Blood. 2002 Jul 15;100(2):420-6.

PMID:
12091331
38.

[Convulsions during treatment of acute lymphoblastic leukemia in children].

Mainero G, Barisone E, Boffi P, Farinasso L, Landolfi C, Dalponte S, Sicca E, Papalla F, Miniero R, Madon E.

Minerva Pediatr. 2000 Apr;52(4):205-14. Italian.

PMID:
11995204
39.

Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica.

Rizzari C, Valsecchi MG, Aricò M, Conter V, Testi A, Barisone E, Casale F, Lo Nigro L, Rondelli R, Basso G, Santoro N, Masera G; Associazione Italiano Ematologia Oncologia Pediatrica.

J Clin Oncol. 2001 Mar 1;19(5):1297-303.

PMID:
11230471
40.

Deletion of parental GST genes as a possible susceptibility factor in the etiology of infant leukemia.

Garte S, Taioli E, Crosti F, Sainati L, Barisone E, Luciani M, Jankovic M, Biondi AG.

Leuk Res. 2000 Nov;24(11):971-4.

PMID:
11086181
41.

Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).

Consolini R, Legitimo A, Rondelli R, Guguelmi C, Barisone E, Lippi A, Cantù-Rajnoldi A, Aricò M, Conter V, Cocito MG, Putti MC, Pession A, Masera G, Biondi A, Basso G.

Haematologica. 1998 Nov;83(11):967-73.

42.

Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia.

Lanza C, Volpe G, Basso G, Gottardi E, Barisone E, Spinelli M, Ricotti E, Cilli V, Perfetto F, Madon E, Saglio G.

Br J Haematol. 1997 May;97(2):460-2.

PMID:
9163615
43.

[In vivo dosimetry for the evaluation of the irradiation dose for the thyroid after prophylactic cerebral irradiation in leukemia of children].

Ricardi U, Rossi G, Tessa M, Barisone E, Besenzon L, Corrias A, Monetti U, Verna R, Urgesi A.

Cancer Radiother. 1997;1(1):85-7. French. No abstract available.

PMID:
9265538
44.

[Toxicity of high dose methotrexate repeated infusions in children treated for acute lymphoblastic leukemia and osteosarcoma].

Ridolfi L, Barisone E, Vivalda M, Vivenza C, Brach Del Prever A, Leone L, Miniero R.

Minerva Pediatr. 1996 May;48(5):193-200. Italian.

PMID:
8926955
45.

Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: correlation with chemotherapy intensity and clinical outcome.

Lanza C, Gottardi E, Gaidano G, Vivenza C, Parziale A, Perfetto F, Fornaci M, Barisone E, Madon E, Basso G, Saglio G.

Leuk Res. 1996 May;20(5):441-3.

PMID:
8683984
46.

Pre-B acute lymphoblastic leukemia in a patient with partial lipodystrophy and acanthosis nigricans.

Franceschini P, Barisone E, Signorile F, Vardeau MP, Guala A, Franceschini D, Vivenza C, Bianchi M, Miniero R.

Panminerva Med. 1995 Dec;37(4):248-51.

PMID:
8710409
47.

[Acute lymphoblastic leukemia in adolescents].

Barisone E, Vivenza C, Oderda S, Saracco P, Vivalda M, Vai S, Madon E, Miniero R.

Minerva Pediatr. 1995 Jul-Aug;47(7-8):277-83. Italian.

PMID:
7476754
48.

Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

Aricò M, Basso G, Mandelli F, Rizzari C, Colella R, Barisone E, Zanesco L, Rondelli R, Pession A, Masera G.

Cancer. 1995 Apr 1;75(7):1684-93.

PMID:
8826928
49.

Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias.

Cimino G, Rapanotti MC, Rivolta A, Lo Coco F, D'Arcangelo E, Rondelli R, Basso G, Barisone E, Rosanda C, Santostasi T, et al.

Leukemia. 1995 Mar;9(3):391-5.

PMID:
7885037
50.

Acute lymphoblastic leukemia in a girl treated for osteosarcoma.

Miniero R, Barisone E, Vivenza C, Brach del Prever A, Besenzon L, Cordero di Montezemolo L, Madon E.

Pediatr Hematol Oncol. 1995 Mar-Apr;12(2):185-8.

PMID:
7626388

Supplemental Content

Loading ...
Support Center